AAOI
Applied Optoelectronics, Inc.
AAOI offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
IBEX
IBEX Limited
IBEX has a slight edge over AAOI overall, supported by lower modeled downside and stronger fundamentals.
AAOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
AAOI's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
IBEX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
IBEX's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
AAOI PE Valuation
AAOI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
IBEX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $33.48 | -39% |
| Fair | 13x | $42.92 | -22% |
| Forward | 14x | $54.87 | — |
| Current | 17x | $54.87 | — |
| Expensive | 20x | $66.14 | +21% |
Historical ranges are pointers, not guarantees.
IBEX's PE is in its expensive range at 17x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its fair range.
AAOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
AAOI has the edge over IBEX on the outlook, with more favorable profitability expectations.
IBEX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for IBEX, with profitability holding steady.
AAOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.98 | — |
| Q3 2026 | -$0.42 | +$3.02 |
| Q2 2026 | -$0.77 | +$2.81 |
| Q1 2026 | -$0.65 | +$3.43 |
| Q4 2025 | -$0.64 | +$3.86 |
| Q3 2025 | -$3.44 | -$1.41 |
| Q2 2025 | -$3.58 | -$1.70 |
| Q1 2025 | -$4.08 | -$2.29 |
| Q4 2024 | -$4.50 | -$2.75 |
AAOI is still losing money, but far less than before: $0.42 per share over the past year, against $4.50 at its worst in late 2024.
IBEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.95 | +20% |
| Q3 2026 | $3.30 | +20% |
| Q2 2026 | $3.13 | +33% |
| Q1 2026 | $3.17 | +39% |
| Q4 2025 | $3.01 | +42% |
| Q3 2025 | $2.75 | +46% |
| Q2 2025 | $2.36 | +28% |
| Q1 2025 | $2.28 | +49% |
| Q4 2024 | $2.12 | +35% |
IBEX has the edge over AAOI on earnings quality, reporting a profit while its opponent remains loss making.
AAOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $269.9M | +127% |
| Q2 2026 | $191.9M | +86% |
| Q1 2026 | $151.1M | +51% |
| Q4 2025 | $134.3M | +34% |
| Q3 2025 | $118.6M | +82% |
| Q2 2025 | $103M | +138% |
| Q1 2025 | $99.9M | +146% |
| Q4 2024 | $100.3M | +66% |
AAOI has the edge over IBEX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +15 points |
| Q2 2026 | -13% | +2.6 points |
| Q1 2026 | -8.6% | +0.3 points |
| Q4 2025 | -8.6% | -2.1 points |
| Q3 2025 | -15% | +10 points |
| Q2 2025 | -16% | +45 points |
| Q1 2025 | -8.9% | +44 points |
| Q4 2024 | -6.5% | +1 points |
AAOI's operating margin was −0.5% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2019.
IBEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $175.2M | +16% |
| Q2 2026 | $164.3M | +12% |
| Q1 2026 | $164.4M | +17% |
| Q4 2025 | $164.2M | +17% |
| Q3 2025 | $151.2M | +17% |
| Q2 2025 | $147.1M | +18% |
| Q1 2025 | $140.7M | +11% |
| Q4 2024 | $140.7M | +6.1% |
IBEX's revenue has grown year over year for 10 quarters in a row: $175M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | +1.4 points |
| Q2 2026 | 6% | -2.3 points |
| Q1 2026 | 9.8% | +0.4 points |
| Q4 2025 | 9.3% | +0.8 points |
| Q3 2025 | 9.1% | +2.1 points |
| Q2 2025 | 8.3% | -2 points |
| Q1 2025 | 9.5% | +0.6 points |
| Q4 2024 | 8.5% | +3.2 points |
IBEX has the edge over AAOI on profitability, with a higher operating margin.
AAOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$369.9M | -$291.2M |
| Q2 2026 | -$265.3M | -$174.4M |
| Q1 2026 | -$143.6M | -$64.3M |
| Q4 2025 | -$104.6M | -$51.6M |
| Q3 2025 | -$78.7M | -$58M |
| Q2 2025 | -$91M | -$86M |
| Q1 2025 | -$79.3M | -$45.1M |
| Q4 2024 | -$53M | -$48.4M |
AAOI has burned cash in almost every quarter: −$883M over the past year, against −$302M the year before.
IBEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.2M | +14% |
| Q2 2026 | $21.7M | -4.9% |
| Q1 2026 | $6.6M | +85% |
| Q4 2025 | -$5.1M | -$1.9M |
| Q3 2025 | $8M | +94% |
| Q2 2025 | $22.8M | +50% |
| Q1 2025 | $3.6M | -63% |
| Q4 2024 | -$3.2M | +$1.4M |
IBEX has the edge over AAOI on cash generation, producing positive trailing cash flow while its opponent burns cash.
AAOI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.7% | +6.3M shares |
| 1 year | +39% | +24.5M shares |
| 3 years | +168% | +55.1M shares |
| 5 years | +224% | +60.7M shares |
| Available history | +340% | +67.9M shares |
AAOI has 88M diluted shares, up 39% from a year ago.
IBEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +187K shares |
| 1 year | +2.6% | +386K shares |
| 3 years | -21% | -3.9M shares |
| 5 years | -21% | -3.9M shares |
| Available history | -15% | -2.7M shares |
IBEX has the edge over AAOI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.5M |
| Q2 2026 | $4.2M |
| Q1 2026 | $4.6M |
| Q4 2025 | $2.8M |
| Q3 2025 | $2.8M |
| Q2 2025 | $1.6M |
| Q1 2025 | $25.1M |
| Q4 2024 | $46.6M |
IBEX spent $16M buying back its own shares over the past year, down 79% from the year before.
AAOI Net Leverage
AAOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IBEX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -0.2x | Net Cash |
IBEX has more cash than debt.
AAOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 4.8 | Oversold |
AAOI's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
IBEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.3 | Overbought |
| Stochastic | 91.0 | Overbought |
IBEX's weekly RSI is 78 (overbought) and its Stochastic is 91 (overbought).
AAOI PE vs Technology Sector
AAOI has no meaningful PE right now: it lost money over the past year.
IBEX PE vs Technology Sector
| Metric | IBEX | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 28x | 40% below |
| PE % | 73 | 37 | 36 pts above |
IBEX is trading at 17x earnings, a 40% discount to the Technology sector's median of 28x.
AAOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.2 | 34% below |
| 20 week MA | $100.6 | 47% below |
| 50 week MA | $100.3 | 47% below |
| 100 week MA | $62.3 | 15% below |
| 200 week MA | $36.9 | 43% above |
AAOI has fallen below most of its moving averages, though it's still 43% above its 200-week average.
IBEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $46.8 | 17% above |
| 20 week MA | $40.6 | 35% above |
| 50 week MA | $35.5 | 54% above |
| 100 week MA | $32.3 | 70% above |
| 200 week MA | $25.5 | 115% above |
IBEX has the edge over AAOI on trend strength, trading above more of its moving averages.
AAOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $8.77 | -24% |
| 2021 | $8.77 | $5.64 | -36% |
| 2022 | $5.64 | $1.95 | -65% |
| 2023 | $1.95 | $19.3 | +891% |
| 2024 | $19.3 | $37.7 | +95% |
| 2025 | $37.7 | $37.2 | -1.5% |
| 2026 YTD | $37.2 | $52.9 | +42% |
AAOI's yearly returns have swung widely, from +891% in 2023 to −65% in 2022. It's up 42% so far in 2026.
IBEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.4 | $20.1 | +30% |
| 2021 | $20.1 | $13.9 | -31% |
| 2022 | $13.9 | $25.6 | +84% |
| 2023 | $25.6 | $19.0 | -26% |
| 2024 | $19.0 | $21.4 | +13% |
| 2025 | $21.4 | $38.5 | +80% |
| 2026 YTD | $38.5 | $54.9 | +43% |
IBEX has the edge over AAOI on returns for 2026, with the stronger performance.